Advertisement
Screener

Lifeward Ltd. (LFWD) Deferred Tax Assets, Operating Loss Carryforwards

2.1 / 5 stars · 39/93 Roast Me

Lifeward Ltd. Deferred Tax Assets, Operating Loss Carryforwards

Lifeward Ltd. (LFWD) had Deferred Tax Assets, Operating Loss Carryforwards of $76.69 million as of 2025-12-31, per its 10-K filed 2026-03-18.

Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-18

  • 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $76.69M.
  • 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $70.43M.
  • 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $64.09M.
  • 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $50.83M.
Period endDeferred Tax Assets, Operating Loss Carryforwards
2025-12-31$76.69M
10-K · filed 2026-03-18
2024-12-31$70.43M
10-K · filed 2026-03-18
2023-12-31$64.09M
10-K · filed 2025-03-07
2022-12-31$50.83M
10-K · filed 2024-02-27
2021-12-31$47.32M
10-K · filed 2023-02-23
2020-12-31$41.94M
10-K · filed 2022-02-24
2019-12-31$35.05M
10-K · filed 2021-02-18
2018-12-31$28.03M
10-K · filed 2020-02-20
2017-12-31$24.97M
10-K · filed 2019-02-08
2016-12-31$20.94M
10-K · filed 2018-03-08
2015-12-31$14.96M
10-K · filed 2017-02-17
2014-12-31$9.15M
10-K · filed 2016-02-29
2013-12-31$5.74M
20-F · filed 2015-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
ENvue Medical, Inc. (FEED)United States$0.011B
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
Bone Biologics Corp (BBLG)United States$0.001B
LogicMark, Inc. (LGMK)United States$0.000B
ALPHA PRO TECH LTD (APT)$0.052B13.63
Envoy Medical, Inc. (COCH)United States$0.056B
MYOMO, INC. (MYO)United States$0.065B-2.85
Safe Pro Group Inc. (SPAI)United States$0.090B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
NutriBand Inc. (NTRB)United States$0.109B